NL-OMON20717尚未招募不适用
The role of intestinal microbiota in breast cancer treatment with hormone therapy: a pathway to new therapeutic options
Maastricht University Medical Center (MUMC+)0 个研究点目标入组 132 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Postmenopausal estrogen receptor positive breast cancer patients in curative setting starting with hormone therapy with either aromatase inhibitors or tamoxifen
- •Willing and able to undergo all study procedures
排除标准
- •HER2+ breast cancer
- •Metastatic disease
研究者
相似试验
已完成
不适用
The role of intestinal microbiota in breast cancer treatment with hormone therapy: a pathway to new therapeutic options1000629110006232Breast cancerNL-OMON53061Medisch Universitair Ziekenhuis Maastricht66
Unknown
不适用
Intestinal Microbiota of Breast Cancer Patients Undergoing ChemotherapyMicrobiotaNCT04138979First Affiliated Hospital of Harbin Medical University80
进行中（未招募）
不适用
Breast Cancer and Its Relationship With the MicrobiotaBreast CancerNCT03885648Universidad de Granada150
已完成
不适用
Engineering Gut Microbiome to Target Breast CancerBreast CancerNCT03358511Mayo Clinic7
已完成
不适用
Probiotics and Breast HealthBreast Cancer FemaleNCT03290651Lawson Health Research Institute60